-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $97 at Brookline Capital Markets
-
-
-
-
-
-
-
Bernstein on US Pharma and Biotech: Who might buy whom?
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $108 at RBC Capital
-
-
-
-
-
-
-
Wolfe Research Downgrades Kymera Therapeutics (KYMR) to Peerperform
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $120 at Oppenheimer
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $80 at Truist Securities
-
-
-
-
-
-
-
Guggenheim Assumes Kymera Therapeutics (KYMR) at Buy
-
434,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

